Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial Meeting Abstract
| Authors: | Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Mercade, T. M.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; Reinacher-Schick, A. C.; Tortora, G.; Algul, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K.; Schlienger, K.; Locker, G. Y.; Golan, T. |
| Abstract Title: | Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-06-20 |
| Language: | English |
| ACCESSION: | WOS:000489109800010 |
| DOI: | 10.1200/JCO.2019.37.18_suppl.LBA4 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA4 -- Source: Wos |
